Page last updated: 2024-10-20

pyridoxamine and Heart Failure

pyridoxamine has been researched along with Heart Failure in 1 studies

Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.

Research Excerpts

ExcerptRelevanceReference
"Pyridoxamine was used as the antagonist of advanced glycation end products (AGEs)."1.42Advanced glycation end products induced immune maturation of dendritic cells controls heart failure through NF-κB signaling pathway. ( Cao, W; Chen, J; Chen, S; Chen, X; Chen, Y; Huang, H; Liu, P, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cao, W1
Chen, J1
Chen, Y1
Chen, S1
Chen, X1
Huang, H1
Liu, P1

Other Studies

1 other study available for pyridoxamine and Heart Failure

ArticleYear
Advanced glycation end products induced immune maturation of dendritic cells controls heart failure through NF-κB signaling pathway.
    Archives of biochemistry and biophysics, 2015, Aug-15, Volume: 580

    Topics: Animals; Bone Marrow; Cardiotonic Agents; Cell Differentiation; Coculture Techniques; Dendritic Cell

2015